PK/PD Comparison of Guanfacine ER and IR

NCT01904526 ↗

Phase 2 Completed 5 enrolled Yale University National Institute on Drug Abuse (NIDA) · collab

NaSingle-groupOpen-labelOther

Summary

Evaluate whether a 4mg/day or 6/mg day dose of extended-release guanfacine produces pharmacokinetic/dynamic (PK/PD) properties similar to 3mg/day immediate release guanfacine.

Timeline

Start: 2013-07
Primary completion: 2016-12
Completion: 2016-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Guanfacine	Small molecule	3 mg	—
Subject	Guanfacine	Small molecule	4 mg	—
Subject	Guanfacine	Small molecule	6 mg	—

Indications

No indication recorded.